Technology Matters: How the Pap Test Protects Your Patients

Article

The Pap test reduces the incidence of cervical cancer and its precursors for women around the world but has limitations in sensitivity and accuracy.

Liquid-based cytology improves detection of dysplasia and cervical malignancy while producing fewer unsatisfactory or insufficient results. This supplement examines the science, development and clinical benefits of ThinPrep® - the first FDA-approved, liquid-based cytological testing method for women aged 30 and older.

Read this online supplement to learn more about the latest in developments in cervical cancer screening.

Download Supplement

 

 

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Related Content
© 2024 MJH Life Sciences

All rights reserved.